He bought it to increase his healthcare holdings. They have several business: prescriptions, medical devices, a huge consumer business, and vaccines. He's waiting for med. devices to pick up after operations resume globally after Covid. JNJ and Merck seem to lag the others in vaccines, but there'll be many opportunities to sell vaccines--vaccines will be a big winner for JNJ.
vs. Tourmaline Oil Like ENB, it faces the same regulatory approval headwinds; will Biden approve Keystone XL? TC still has many pipelines operating and pays a safe dividend. You can't compare this to Tourmaline, like apples vs. oranges.